Cell and Gene Therapy Market Scenario | DelveInsight
Future Perspectives Of CAR-T Cell Therapy Market In Acute Lymphoblastic Leukemia (ALL)
recent-pharma-news-updates-for-bluerock-omniscient-neuspera-rivus
BlueRock secures FDA fast track; Omni...

BlueRock Therapeutics secures FDA fast track for Parkinson’s disease cell therapy BlueRock, a Bayer subsidi...

pharma-happenings-for-arrowhead-sartorius-sirnaomics-agc-biologics
Arrowhead’s ARO-ENaC Clinical T...

Arrowhead Halts its ARO-ENaC Phase 1/2 Clinical Trial  Arrowhead Pharmaceuticals recently notified abo...

Intellia's Quest with CRISPR; Innovent, Synaffix ADC Tech Deal; Lilly's Diabetes Blockbuster Tirzepatide; Polyphor’s Bleak Future
Intellia’s Quest with CRISPR; I...

A New Dawn for CRISPR, Intellia Edits Cells Inside the Body Intellia Therapeutics, along with its partner R...

recent-pharma-happenings-for-insilico-sanofi-medtronic-blackstone-cellex
Insilico Medicine raises $255M; Sanofi & Translate Bio initiate trial; Medtronic gains expan...

Insilico Medicine raises USD 255 Million for AI drug discoveryInsilico Medicine, a Hong Kong-based global leader in end-to-end artificial intelligence for target discovery, small molecule chem...


Horizon-Arrowhead-deal-Dr-Reddy-Lab-Drug-US-Launch-Targovax-ONCOS-102;-RedHill-Oral-Opaganib-COVID-19
Horizon/ Arrowhead Deal; Dr Reddy’s Lab’s Drug US Launch; Targovax’s ONCOS-102; RedHill...

Horizon Dishes Out Million Dollars to get Arrowhead's RNAi DrugArrowhead Pharmaceuticals and Horizon Therapeutics have announced a research and development collaboration to advance the treatme...


recent-pharma-happenings-for-mallinckrodt-rayzebio-vectory-umoja
Mallinckrodt earns FDA nod for skin therapy; RayzeBio secures $108M; VectorY raises $38M; Umoja b...

Mallinckrodt earns FDA nod for regenerative skin therapy for burnsMallinckrodt plc’s Stratagraft gained FDA approval for use in deep partial-thickness thermal burns. The company said regenerat...


latest-biotech-healthcare-pharma-news-updates-aelis-farma-alcyone-progentec-gsk-kozin
Aelis Farma pockets $30M; Alcyone unveils $23M for AAV gene therapies; Progentec and GSK collabor...

Aelis Farma pockets USD 30 Million upfront in cannabis use disorder deal with IndiviorIndivior speculates that Aelis Farma has what it takes to bring cannabis use disorder therapy into the cli...


recent-pharma-news-updates-for-biogen-novo-nordisk-bluebird-bio
Biogen’s Alzheimer’s Drug; FDA approval to Novo Nordisk’s Wegovy; Bluebird’s Gene Therapy

Verdict for Biogen’s Long-Awaited Alzheimer’s Drug Is Finally Here  The USFDA finally gave approval to eagerly-anticipated Biogen’s Drug Aducanumab for the treatment of Alzheimer’s d...


Latest-pharma-biotech-news-updates-for-pieris-genentech-xilio-merck-bms-xencor
Pieris-Genentech deal; Xilio inks deal with Merck; BMS taps Xencor’s tech; GenSight’s...

Pieris Pharmaceuticals declares Respiratory and Ophthalmology deal with GenentechPieris, a clinical-stage biotechnology company, declared that it has entered into a multi-program research coll...


Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmo...

According to WHO, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death g.....

Myelodysplastic Syndrome (MDS) Market Analysis
Myelodysplastic Syndrome ...

Well, MDS being one of the rare blood cancers, has been into the limelight of researchers since a de.....

Prostate Cancer Market
Prostate Cancer...

Prostate Cancer is the second most common malignancy in men worldwide, after lung cancer. Most Prost.....

Editor's Pick
Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

Healthcare Data Breach: What it Means for Companies and the Consumer?

Data and analytics today are playing a major role in the organization’s growth. Stakeho...

Onychomycosis Therapy Market Set to Balloon Up as Emerging Novel Therapies Co...

Onychomycosis is the most commonly prevalent nail infection in adults. It is a fungal i...

Angelman syndrome Pipeline: Unmet needs call for a robust pipeline

The necessity of a robust Angelman syndrome pipeline is indispensable at the current mo...

The New Buzz of Transcranial Stimulation Devices in the Neurological Disorder...

Neurological disorders are one of the major causes of death and disability across the g...